Cargando…
Receptor Tyrosine Kinases as Therapeutic Targets in Rhabdomyosarcoma
Rhabdomyosarcomas (RMSs) are the most common soft tissue sarcomas of childhood and adolescence. To date, there are no effective treatments that target the genetic abnormalities in RMS, and current treatment options for high-risk groups are not adequate. Over the past two decades, research into the m...
Autores principales: | Crose, Lisa E. S., Linardic, Corinne M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022188/ https://www.ncbi.nlm.nih.gov/pubmed/21253475 http://dx.doi.org/10.1155/2011/756982 |
Ejemplares similares
-
Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
por: Hinson, Ashley R. P., et al.
Publicado: (2013) -
Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma
por: Slemmons, Katherine K., et al.
Publicado: (2015) -
Embryonic Signaling Pathways and Rhabdomyosarcoma: Contributions to Cancer Development and Opportunities for Therapeutic Targeting
por: Belyea, Brian, et al.
Publicado: (2012) -
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
por: De Giovanni, Carla, et al.
Publicado: (2021) -
A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas
por: Deel, Michael D., et al.
Publicado: (2015)